CMV and Immunosenescence: from basics to clinics
dc.contributor.author | Solana, Rafael | |
dc.contributor.author | Tarazona, Raquel | |
dc.contributor.author | Aiello, Allison E | |
dc.contributor.author | Akbar, Arne N | |
dc.contributor.author | Appay, Victor | |
dc.contributor.author | Beswick, Mark | |
dc.contributor.author | Bosch, Jos A | |
dc.contributor.author | Campos, Carmen | |
dc.contributor.author | Cantisán, Sara | |
dc.contributor.author | Cicin-Sain, Luka | |
dc.contributor.author | Derhovanessian, Evelyna | |
dc.contributor.author | Ferrando-Martínez, Sara | |
dc.contributor.author | Frasca, Daniela | |
dc.contributor.author | Fulöp, Tamas | |
dc.contributor.author | Govind, Sheila | |
dc.contributor.author | Grubeck-Loebenstein, Beatrix | |
dc.contributor.author | Hill, Ann | |
dc.contributor.author | Hurme, Mikko | |
dc.contributor.author | Kern, Florian | |
dc.contributor.author | Larbi, Anis | |
dc.contributor.author | López-Botet, Miguel | |
dc.contributor.author | Maier, Andrea B | |
dc.contributor.author | McElhaney, Janet E | |
dc.contributor.author | Moss, Paul | |
dc.contributor.author | Naumova, Elissaveta | |
dc.contributor.author | Nikolich-Zugich, Janko | |
dc.contributor.author | Pera, Alejandra | |
dc.contributor.author | Rector, Jerrald L | |
dc.contributor.author | Riddell, Natalie | |
dc.contributor.author | Sanchez-Correa, Beatriz | |
dc.contributor.author | Sansoni, Paolo | |
dc.contributor.author | Sauce, Delphine | |
dc.contributor.author | van Lier, Rene | |
dc.contributor.author | Wang, George C | |
dc.contributor.author | Wills, Mark R | |
dc.contributor.author | Zieliński, Maciej | |
dc.contributor.author | Pawelec, Graham | |
dc.date.accessioned | 2015-08-07T17:46:23Z | |
dc.date.available | 2015-08-07T17:46:23Z | |
dc.date.issued | 2012-10-31 | |
dc.identifier.citation | Immunity & Ageing. 2012 Oct 31;9(1):23 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/112841 | en_US |
dc.description.abstract | Abstract Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop. | |
dc.title | CMV and Immunosenescence: from basics to clinics | |
dc.type | Article | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/112841/1/12979_2012_Article_130.pdf | |
dc.identifier.doi | 10.1186/1742-4933-9-23 | en_US |
dc.language.rfc3066 | en | |
dc.rights.holder | Solana et al.; licensee BioMed Central Ltd. | |
dc.date.updated | 2015-08-07T17:46:23Z | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.